Effects of Bariatric Surgery on Cardiovascular Risk Profile in Relation to Inflammatory Parameters: Endothelial Phenotyping and Analysis of the Cross-talk Between Adipose Tissue and Endothelium
BARIHEART
1 other identifier
interventional
85
1 country
1
Brief Summary
This research project aims to study how obesity affects the heart and metabolism, and how these effects change after significant weight loss following bariatric surgery. In particular, we want to look at how blood vessels and fat tissue function in people with obesity, to detect early signs of vascular problems and understand how fat tissue communicates with blood vessels. Our main idea is that obesity disrupts the normal function of blood vessels, partly due to substances released by fat tissue and changes in gut bacteria. We believe that 6 and 12 months after surgery - with proper weight loss - these problems will gradually improve. We expect to see better blood vessel function and lower levels of inflammation and fat-related substances in the blood, which could significantly reduce the overall risk of heart disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2024
CompletedFirst Submitted
Initial submission to the registry
August 5, 2025
CompletedFirst Posted
Study publicly available on registry
August 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 11, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 11, 2026
May 4, 2026
August 1, 2025
2 years
August 5, 2025
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
changes at the vascular tissue
Measurement of circulating endothelial cells ( cells/µL)
12 months
To analyze the changes adipose tissue
Cardiac CT for assessment of epicardial adipose tissue. Volume quantification by tracing (cm³)
from enrollment to the end of study at 12 month
Study Arms (1)
Patients who are hospitalized and undergoing either gastric bypass or sleeve gastrectomy surgery
OTHERInterventions
This study includes a comprehensive set of laboratory and clinical investigations to evaluate the cardiovascular and metabolic impact of obesity and its modulation after bariatric surgery. Multiple biological samples (blood, urine, stool, and omental adipose tissue) will be collected at baseline and during follow-up.
Eligibility Criteria
You may qualify if:
- Adults (≥ 18 years old); Patients with obesity (Body Mass Index ≥ 30 kg/m²); Patients scheduled to undergo bariatric surgery via mini-gastric bypass or sleeve gastrectomy; Patients able to give their consent and to provide signed and dated informed consent for the processing of personal data; Willingness to attend follow-up visits and undergo all assessments required by the study protocol.
You may not qualify if:
- Active systemic inflammatory diseases (e.g., chronic inflammatory bowel diseases, chronic rheumatologic diseases); Acute or chronic infections Severe anemia or coagulation disorders; Moderate to severe chronic kidney disease; Active malignancies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maria Cecilia Hospital
Cotignola, Ravenna, 48033, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2025
First Posted
August 20, 2025
Study Start
November 11, 2024
Primary Completion (Estimated)
November 11, 2026
Study Completion (Estimated)
November 11, 2026
Last Updated
May 4, 2026
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be publicly shared. However, de-identified data may be made available to qualified researchers upon reasonable request to the study center and the Principal Investigator. All data will be processed in compliance with the General Data Protection Regulation (GDPR - EU Regulation 2016/679), ensuring the confidentiality, integrity, and protection of participants' personal information."